Citation: López-Luppo M, Catita J, Ramos D, et al. Cellular senescence is associated with human retinal microaneurysm formation during aging. Invest Ophthalmol Vis Sci. 2017;58:283258: -284258: . DOI:10.1167 PURPOSE. Microaneurysms are present in healthy old-age human retinas. However, to date, no age-related pathogenic mechanism has been implicated in their formation. Here, cellular senescence, a hallmark of aging and several age-related diseases, has been analyzed in the oldage human retina and in the retina of a progeric mouse.
M
icroaneurysms are focal dilations of capillaries most frequently seen in the retina, although they can also be found in other organs, such as kidney and heart. 1,2 Capillary microaneurysms are a clinicopathologic hallmark of human diabetic retinopathy, [3] [4] [5] [6] [7] but they are also present in healthy oldage human retinas. 8, 9 Several mechanisms have been implicated in retinal microaneurysm formation during diabetes, including cell death, impaired angiogenesis, changes in intraluminal rheology, and basement membrane alterations. [10] [11] [12] [13] [14] However, to date, little is known about the mechanisms involved in the formation of age-related retinal microaneurysms and whether these mechanisms are different from those occurring during diabetes.
Cellular senescence is one of the hallmarks of aging and can be defined as a stable arrest of the cell cycle. [15] [16] [17] Recently, it has been proposed that the central purpose of cellular senescence is to initiate a sequence of processes that eliminate damaged cells and culminate in tissue regeneration. 18 This beneficial process can be corrupted, particularly in aged tissues, leading to an accumulation of senescent cells that may aggravate tissue dysfunction through a senescenceassociated phenotype, which is particularly enriched in proinflamatory cytokines and matrix metalloproteinases. 17, 19 Several vascular pathologies have been associated with cellular senescence, including brain and coronary aneurysms among others. 20, 21 However, the overall effect of senescence during the aneurysm formation is not well understood.
The main objectives of this study were (1) to analyze cellular senescence in the old-age human retina and (2) to explore whether senescence is implicated in the formation of retinal microaneurysms during aging. Here we confirm that cellular senescence occurred in old-age human retinas. Retinal neurons but not neuroglia cells underwent cellular senescence during aging. In addition, blood vessels displayed a senescent phenotype characterized by p16, p53, p21, and p62 overexpression, senescent-associated b-galactosidase (SA-b-gal) activity, and accumulation of lipofuscin. In comparison with senescent capillaries, p16, p53, and p21 were up-regulated in microaneurysms. Apoptosis and cellular senescence co-occurred in retinal microaneurysms of old-age human retinas. Senescent endothelial cells expressed p16 in the inner part of their cellular membrane, where p16 colocalized with the b 1 integrin subunit. In addition, fibronectin of the basement membrane coated discontinuously the abluminal surface of senescent endothelial cells. All together, these data could suggest that p16 induces anoikis by direct interaction with the fibronectin receptor a 5 b 1 integrin. To get further insight into the age-mediated mechanisms implicated in microaneurysm formation, retinas from a progeric mouse model deficient in Bmi1 that overexpress p21 were analyzed. Retinal blood vessels in Bmi1 À/À mice displayed an aging phenotype characterized by enlarged caveolae and accumulation of lipofuscin granules. Although retinal microaneurysms do not generally develop in mouse models, Bmi1 À/À mice showed abundant microaneurysms in their retinal superficial vascular plexus. The presence of retinal microaneurysms in Bmi1 À/À mice reinforces the hypothesis that cellular senescence is associated with the pathogenesis of retinal microaneurysms in elderly people.
MATERIALS AND METHODS

Human Retinas
Human eye samples were obtained from voluntary body donations to the Faculty of Medicine at Universitat Autònoma de Barcelona (UAB). The procedure of body donation was in accordance with the Catalonian law (DECRET 297/1997, de 25 de Novembre) and was approved on March 27, 2015 by the ethics committee Comisió d'Ètica en l'Experimentació Animal i Humana (CEEAH/UAB). All participants in the study gave, during their lifetime, written consent for donation of their bodies after death for teaching and research purposes. Our laboratory received human eye samples without knowledge of the donor's identity. Only biological data, such as sex, age, clinical history, and cause of death, were available (Table) . Eyes were obtained from 17 donors: 14 old-age donors ( X ¼ 85.28 years old) and 3 middle-age donors ( X ¼ 40 years old). Corneas were removed, and retinas were examined using a dissecting microscope for pathologic evidence of neovascularization. None of the donors had history of diabetic disease (Table) , nor did they present characteristic lesions of diabetic proliferative retinopathy. However, the possibility of undiagnosed asymptomatic nonproliferative diabetic retinopathy cannot be ruled out in this pool of old-age donors. Eyes were fixed in a solution of paraformaldehyde 4% with picric acid in 0.01 M PBS for 24 hours. Time between death and fixation was critical to obtain adequate samples for immunohistochemistry and electron microscopy. The average time for fixation in our study was 7 hours (Table) . Next, eyes were washed in PBS, partially dehydrated, and maintained in a 70% alcohol solution at 48C. The storage of prefixed eyes in this cold alcoholic solution allowed to perform immunohistochemistry and electron microscopy during a long period of time. For their immunohistochemical analysis, retinal fragments of about 3 mm 2 were dissected out from the prefixed eyes and processed adequately for each experiment.
Animals
Two-month-old Bmi1
À/À Rd1 mice, yielded from P. Muñoz-Cànoves (Cell Biology Group, Department of Experimental and Health Sciences, Pompeu Fabra University), were generated by intercrossing heterozygotes (Bmi1 þ/À ) in a FVB/NJ background. Bmi1 þ/þ Rd1 littermates were used as controls. Animal care and experimental procedures were performed according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by CEEAH/UAB (Permit 1666).
Immunohistochemistry
Retinal fragments from all donors were used for immunohistochemistry (Table) . Paraffin-sections and whole mount retinas were incubated overnight at 48C with the following antibodies: mouse anti-p16 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 1:50 dilution; mouse anti-p53 (Abcam, Cambridge, UK) at 1:100 dilution; rabbit anti-p21 (Abcam) at 1:100 dilution; rabbit anti-protein gene product 9.5 (PGP) (DakoCytomation, Glostrup, Denmark) at 1:350 dilution; rabbit anti-parvalbumin at 1:100 dilution; rabbit anti-glutamine synthetase (GS) (SigmaAldrich Corp., St. Louis, MO, USA) at 1:500 dilution; rabbit anti-glial fibrillary acidic protein (GFAP) (DakoCytomation) at 1:1000 dilution; goat anti-collagen IV (Millipore, Temecula, CA, USA) at 1:20 dilution; rabbit anti-activated caspase3 (Cell Signaling Technology, Inc., Danvers, MA, USA) at 1:250 dilution; rabbit anti-integrin b1 subunit (Abcam) at 1:100 dilution; rabbit anti-fibronectin (BD Pharmigen, San José, CA, USA) at 1:100 dilution, and rabbit anti-p62 (Abcam) at 1:100 dilution. After they were washed in PBS, retinas were incubated at 48C overnight with specific secondary antibodies: biotinylated anti-mouse IgG (Vector Laboratories, Burlingame, CA, USA) at 1:100 dilution; anti-goat IgG Alexa 568 (Invitrogen, Carlsbad, CA, USA) at 1:250 dilution, and anti-rabbit IgG Alexa 
SA-b-gal Assay
SA-b-gal activity was checked as previously described. 22 Briefly, whole mount retinas were fixed at room temperature for 15 minutes in 0.5% glutaraldehyde/PBS (pH 6.0). After fixation, retinas were washed twice in PBS (pH 6.0) and incubated in the X-gal solution at pH 6.0 (5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 1 mM MgCl 2 in PBS solution, pH 7.5) containing 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl b-D-galactopyranoside) (Sigma-Aldrich Corp.) at 378C overnight. In parallel, as a control of the technique, bgal activities were assayed in X-gal solution at pH 4.0 and 7.5. Samples were checked during incubation and the reaction was stopped approximately after 3 hours, when SA-b-gal activity was evident in samples at pH 6 with no change in bgal activity at pH 7.5. Samples were washed several times in PBS to eliminate the X-gal solution and immediately photographed using a stereo microscope (SMZ 1000; Nikon, Tokyo, Japan) fitted with a high-resolution camera (DXM 1200F; Nikon).
Sudan Black B Staining
Paraffin-embedded retinal sections were dewaxed with xylene, rehydrated until 70% ethanol, and stained with Sudan black B (SBB) solution containing 0.7 g SBB (Sigma-Aldrich Corp.) dissolved in 70% ethanol, for 2 to 8 minutes at room temperature. Slides were then immersed into 50% ethanol, washed in distilled water, counterstained with 0.1% Nuclear Fast Red (Aldrich Chem. Co., Milwaukee, WI, USA), and mounted into 40% glycerol/Tris-buffered saline medium for microscopic analysis using an optical microscope (Eclipse E-800; Nikon) and a Nikon digital camera (DXM 1200F; Nikon).
Transmission Electron Microscopic Analysis
Retinal fragments of 1 mm 2 were fixed in 2.5% glutaraldehyde and 2% paraformaldehyde for 2 hours at 48C. After washing in cold phosphate buffer, samples were postfixed in 1% osmium tetroxide, dehydrated through a graded acetone series, and embedded in epoxy resin. Ultrathin sections (70 nm) from resin blocks were stained using lead citrate and 2% uranyl acetate followed by examination in a transmission electron microscope (H-7000; Hitachi Ltd., Tokyo, Japan).
For immunoelectronmicroscopy, after fixation (0.1% glutaraldehyde and 4% paraformaldehyde) and rinsing in 150 mM ammonium chloride, retinal fragments were cryoprotected in increasing concentrations of sucrose (0.5 to 2.3 M) for 3 days. Samples were maintained in liquid nitrogen until cryosubstitution in pure methanol at gradually increasing temperatures from À1208C to À308C for 4 days with Leica EM AFS2 (Leica, Vienna, Austria). Infiltration was achieved by embedding the retinal fragments in resin Lowicryl K4M (EMS, Hatfield, PA, USA) gradually diluted in methanol at À308C overnight, following UV polymerization for 48 hours at À308C. Ultrathin retinal sections (70 nm) from resin blocks were first blocked in PBS containing 20 mM glycine and 1% bovine serum albumin (BSA), followed by incubation with primary mouse antibody against p16 INK4a (Santa Cruz Biotechnology) diluted at 1:10 in the same blocking solution at 48C overnight. After washing in PBS containing 20 mM glycine, sections were incubated with an anti-mouse IgG 15-nm gold (BBI Solutions, Cardiff, UK) diluted 1:25 for 1 hour at room temperature and were washed in PBS and Milli-Q water. Grids were contrasted and examined in the same manner as sections for conventional transmission electron microscopy. To determine whether the gold complex is contributing to the labeling through unspecific bindings to the tissue, the primary antibody was omitted in the protocol.
In Situ Protein Quantification
To analyze p16 expression in the retina, mean fluorescence intensity (MFI) was measured in immunohistochemically labeled retinal paraffin sections of a middle-and an old-aged donor. To measure the expression of activated caspase 3 and the senescence markers p16, p53, and p21 in the microaneurysms, two-dimensional projections of stacks of confocal images were obtained from old-age whole mount retinas by optical sectioning at successive x-y focal planes with a 1 lm vertical step through the entire vessel depth. MFI was measured in 5 to 10 randomly selected microaneurysms and in adjacent areas of nonaffected capillaries from two different aged donors.
Values of MFI were obtained with the Leica LAS AF Lite imaging software according to the equation: MFI ¼ P i ðpÞ np , where i(p) is the intensity of a pixel within the confocal plane, and n(p) is the total number of pixels of the plane. Results are reported in gray values, fluorescent intensity arbitrary units.
Identical image acquisition parameters were applied to all the experiments, which provided comparable images across the different experiments.
Statistical Analysis
Results were expressed as mean 6 SD. Differences between groups were evaluated by paired or unpaired Student's t-test, as appropriate. P < 0.05 was considered significant.
RESULTS
Cellular Senescence in Old-Age Human Retinas
To determine the cellular type and topography of senescent cells in human retinas, the expression of p16, a wellestablished cellular senescence biomarker, 23 was analyzed in immunolabeled paraffin-embedded retinal sections from middle-age and old-age donors. Our results revealed increased p16 expression throughout all retinal layers in old-age donors (Fig.  1) . As an example, quantification of protein fluorescence intensity in a retina from an 85-year-old donor showed that p16 expression was nearly 12 times higher in comparison with a retina from a 42-year-old donor (8.63 fluorescence intensity arbitrary units versus 0.72 fluorescence intensity arbitrary units, respectively). This difference in p16 expression between middle-and old-age human retinas correlates with the variations of p16 expression observed by other authors when comparing young and old tissues. 24 In addition, subcellular localization of p16 changed during aging. Middle-age retinas showed exclusively nuclear p16 expression (Fig. 1A) , whereas in old-age retinas, p16 localization was both nuclear and cytoplasmic (Figs. 1B, 2) . Positive Cellular Senescence During Microaneurysm Formation IOVS j June 2017 j Vol. 58 j No. 7 j 2834 p16 immunoreaction has been described in the nucleus or both in the nucleus and the cytoplasm. 25 However, according to most investigators, p16 staining exclusively seen at cytoplasmic level should be interpreted as false-positive signal. 25 To further investigate which type of retinal cells expressed p16 in old-age retinas, double immunohistochemistry in paraffin-embedded retinal sections was done. Immunolabeling with anti-protein gene product (PGP) 9.5 antibody, a useful marker for human ganglion cells and cones, 26 confirmed the expression of p16 in ganglion cells and rods ( Fig. 2A) . Ganglion cells expressed p16 in their nuclei and cytoplasm, especially at the level of their axons, which form the retinal nerve fiber layer (Figs. 2A, 3B ). Rods only expressed p16 in their nuclei ( Fig.  2A) . Furthermore, as evidenced by immunolabeling against parvalbumin, horizontal cells expressed p16, both in their nuclei and cytoplasm, and amacrine cells expressed p16 only in their nuclei (Fig. 2B ). In contrast with retinal neurons, neuroglial retinal cells did not express p16 in old-age retinas (Figs. 2C, 2D ). Neither astrocytes marked with GFAP 27 nor Müller cells marked with GS, 28 which only expressed p16 in their cytoplasm, showed specific immunostaining for p16.
Cellular Senescence in Old-Age Human Retinal Blood Vessels
To analyze cellular senescence in retinal blood vessels, we performed double immunostaining of whole mount retinas with anti-p16, anti-p53, and anti-p21 antibodies, together with an antibody against collagen IV to evidence blood vessel basement membrane. 29 In comparison with middle-age retinal blood vessels, which did not express senescence biomarkers, old-age retinal blood vessels intensely expressed p16, p53, and p21 (Figs. 3-5) . As previously discussed, subcellular localization of p16 changed from nuclear to both nuclear and cytoplasmic during aging. As expected, a more detailed analysis revealed that p16 was found in the nuclei and cytoplasm of cells of the vascular wall (Fig. 3C ). This was consistent with studies performed in other tissues besides the retina that showed an age-dependent increase of p16 expression in endothelial cells 30 and vascular smooth muscle cells 31 during aging. Although p16, p53, and p21 are considered canonical biomarkers for cellular senescence, 18 SA-b-gal histochemistry, the most widely used assay for senescence, 32 was also performed in old-age retinas. Specific SA-b-gal activity, b-gal enzymatic activity at suboptimal pH (pH 6.0), was observed in endothelial and smooth muscle cells of aged retinal blood vessels (Fig. 6A) . As expected, no staining of b-gal at pH 7.5 and intense staining of b-gal at pH 4.0 were observed in old-age retinas (Fig. 6B) .
Recently, SBB staining for lipofuscin has been recognized as a new method to detect cellular senescence. 33 Similarly to SAb-gal activity, which is based on the increased lysosomal content of senescent cells, 34 lipofuscin is a pigment that aggregates with age in cellular lysosomes. [35] [36] [37] To corroborate cellular senescence, we used this new method and, as expected, old-age retinal blood vessels were positively stained by SBB (Fig. 7) . This confirmed previous results of our group that showed lipofuscin granules in aged human retinal blood vessels using transmission electron microscopy. 9 It has been suggested that autophagy mediates the acquisition of the senescence phenotype. 38 Sequestosome-1, p62, an adaptor protein involved in the delivery of ubiquitinbound cargo to the autophagosome, 39 is up-regulated during senescence, 38 and it has been seen coexpressed with p16 in 
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several pathologies. 40 Our results showed that, in comparison with middle-age retinas, p62 was overexpressed in the blood vessels of old-age retinas (Fig. 8) , confirming the association between cellular senescence and altered autophagy in human retinal blood vessels during aging.
Taken together, the expression of p16, p53, and p21, SA-bgal activity, and SBB staining, as well as overexpression of p62 found in old-age human retinal blood vessels, strongly suggested that they undergo cellular senescence during aging.
Cellular Senescence Was Up-Regulated in Old-Age Human Retinal Microaneurysms
We next assessed the expression pattern of p16, p53, and p21 in retinal microaneurysms. Double immunohistochemistries with anti-p16, anti-p53, and anti-p21antibodies, together with anti-collagen IV antibody, performed in whole mount retinas from old-age humans revealed an increased expression of p16, p53, and p21 in retinal microaneurysms compared with nonaffected adjacent capillary regions (Figs. 9-11 ). Moreover, an accurate quantification of mean fluorescence intensity in microaneurysms and their adjacent nonaffected capillary regions demonstrated that differences in the expression of p16 (74.7 6 21.5 Gy in the microaneurysm versus 16.7 6 5.4 Gy in the capillary wall), p53 (64.89 6 21.06 Gy in the microaneurysm versus 35. 41 6 19.85 Gy in the capillary wall), and p21 (35.37 6 17.38 Gy in the microaneurysm versus 23.11 6 9.061 Gy in the capillary wall) were statistically significant (P < 0.05).
Cellular Senescence and Apoptosis Co-Occurred in Old-Age Retinal Microaneurysms
We previously reported that activated caspase 3, a wellrecognized biomarker for apoptosis, 41 is present in retinal capillaries during aging. 9 Here we show that activated caspase 3 was increased in retinal microaneurysms compared with adjacent nonaffected capillary regions (Fig. 12A) , suggesting that apoptosis of endothelial cells and pericytes is involved in microaneurysm formation during aging. In contrast to other cell types, such as senescent fibroblast that are resistant to apoptotic stimuli, senescent endothelial cells have increased sensitivity to apoptosis. 42 This was consistent with our observations in retinal endothelial cells from old-age donors where (1) the senescent marker lipofuscin, detected by its autofluorescence emission, was associated with activated caspase 3 ( Fig. 12B) and (2) lipofuscin granules were associated with apoptotic bodies, both visualized by transmission electron microscopy (Fig.  12C) .
Senescence and apoptosis pathways could be simultaneously engaged in certain processes or stress responses. 42 In this regard, the p53 senescence marker acts as a nuclear transcription factor that transactivates genes involved in apoptosis, and at the cytoplasmic level, p53 induces mitochondrial outer membrane permeabilization, thereby triggering the release of proapoptotic factors from the mitochondrial intermembrane space. 43 Furthermore, overexpression of p16 induces anoikis, by restoring apoptosis on loss of cellular extracellular anchorage. 44 Anoikis induced by p16 is mediated by the cellular membrane receptor a 5 b 1 integrin that binds extracellular fibronectin. 44 To get further insight into the possible apoptotic function of p16, we analyzed its subcellular localization in old-age human retinal endothelial cells by immunoelectronmicroscopy using a gold-labeled secondary antibody against the anti-p16 antibody. Under transmission electron microscopy, gold beads were found in the inner part of the cellular membrane at the abluminal surface of endothelial cells (Fig. 13) , suggesting that p16 was localized under the cellular membrane close to the extracellular matrix that surrounds blood vessels. To know if p16 protein located under the cellular membrane of aged endothelial cells interacts with the a 5 b 1 integrin, a colocalization study between b 1 integrin subunit and p16 was performed by immunohistochemistry and confocal analysis. As shown in Figure 14A , p16 colocalized with the b 1 subunit, suggesting that part of the apoptosis observed in aged retinal endothelial cells could be mediated by the interaction between p16 and the a 5 b 1 integrin. Furthermore, aged endothelial cells overexpressing p16 showed a discontinuous coverage of fibronectin in their abluminal surface (Fig. 14B ), pointing to anoikis as a possible type of apoptosis that could occur in human retinal endothelial cells during aging. 
Retinal Microaneurysms in Progeric Mice
Polycomb group proteins form large multimeric complexes that silence specific target genes by modifying chromatin organization. 45 Bmi1, a member of the Polycomb group family, is down-regulated in old-age human retinas, 46 and inactivation of Bmi1 in mice induces a premature progeroid-like phenotype in the eye. 47 Bmi1 À/À mice display cataracts, retinal gliosis, loss of heterochromatin, and necroptosis in photoreceptors. 47, 48 Furthermore, Bmi1 deficiency has been associated with activation of p16 in human and mouse retinas, 47, 48 which is consistent with the Bmi1 general function to inhibit the p16/ cyclin-dependent kinase 6/retinoblastoma pathway. 49 To get further insight into age-dependent mechanisms involved in microaneurysm formation, retinal blood vessels were analyzed in 2-month-old Bmi1 À/À mice. Bmi1 þ/þ mice carried a mutation in the rod-specific Phosphodiesterase-6b gene (Rd1 mutation) that produces extensive photoreceptor degeneration and loss of the retinal outer nuclear layer (Fig. 15A) . In contrast, genetic ablation of Bmi1 provided extensive photoreceptor survival 50 and the retina of Bmi1 À/À Rd1 mice showed the outer nuclear layer of photoreceptors (Fig. 15A) . Furthermore, p21 was expressed in blood vessels suggesting that, as happens in humans, retinal blood vessels undergo cellular senescence (Fig.  16) .
In 2-month-old Bmi1 À/À Rd1 mice, retinal blood vessels displayed an aging phenotype characterized by enlarged caveolae, determining the characteristic ''foamy'' aspect of aged endothelial cells 9 ( Fig. 15B) , and accumulation of lipofuscin granules, in both endothelial cells and pericytes (Fig. 15C) . Furthermore, the analysis of whole mount retinas immunohistochemically marked with anti-collagen IV showed multiple microaneurysms located in the superficial vascular plexus of Bmi1 À/À Rd1 mice (Fig. 17) , supporting the idea that cellular senescence could induce the formation of microaneurysms in old-age people.
DISCUSSION
Fifty-five years ago, L. Hayflick and P. Moorhead observed that human fibroblasts exhibited a limited proliferative capacity in culture, a phenomenon that they named ''cellular senescence,'' and speculated that it could be a cause of aging. 51 Here, our results confirm and extend a preliminary study that report cellular senescence during human retinal aging. 46 The canonical senescence biomarker p16 was 12-fold overexpressed in old-age retinas compared with middle-age retinas, supporting a correlation between cellular levels of p16 and the chronological age of essentially all tissues analyzed. 52, 53 Our results also showed that neurons but not neuroglial cells undergo cellular senescence during retinal aging.
Cellular senescence has been implicated in age-dependent eye diseases, such as AMD 54, 55 and more recently glaucoma. 56 Furthermore, cellular senescence has been associated with several vascular diseases, including the formation of brain and coronary aneurysms. 20, 21 Here, we report that retinal microaneurysms overexpress p16, p53, and p21, suggesting that cellular senescence is associated with the pathogenesis of this lesion. Cell death and apoptosis, mechanisms also associated with microaneurysm formation during diabetic retinopathy, 11 co-occur with cellular senescence in old-age retinal microaneurysms from nondiabetic donors.
Although described in some mouse models, such as VEGF transgenic Kimba mice 57 and plateled-derived growth factor (PDGF)-b endothelium restricted-deficient mice, 58 microaneurysms do not generally develop in mouse retina. It has been suggested that this may be caused by the presence of precapillary sphincters, which probably protect capillary beds from hypertensive injury. 59 In this context, it is relevant that, despite how little the mouse retina is prone to develop microaneurysms, a progeric mouse that overexpress p21 in retinal blood vessels displays this lesion. In our opinion, this fact reinforces the hypothesis that cellular senescence is a mechanism associated with retinal microaneurysm formation in aging.
Meta-analysis of more than 300 genome-wide association studies identified the INK4a/ARF locus, which encodes p16, as the genomic locus that is genetically linked to the highest number of age-associated pathologies, including type 2 diabetes. 60 Furthermore, pancreatic b cell senescence has been identified as a player that contributes to the pathogenesis of type 2 diabetes. 61 These observations, together with the similarities noted between our study using nondiabetic old-age donors and previous studies using diabetic donors, 3, 10, 11, 14 could suggest that cellular senescence is a common cause for the development of retinal microaneurysms in both diabetic and aging conditions. Further studies must be launched in the future to enlighten this possibility.
